News: Video: The Pitch

Recce Ltd is bio-technology company that is at the forefront of developing antibiotics to beat super bugs.  RECCE® antibiotics have shown in laboratory tests that they have continued activity against bacteria including superbugs, even after repeated use. Recce is positioned to achieve milestones in both pre-clinical trials for FDA purposes and the development of a pilot plant for flow-system manufacture of RECCE® antibiotics.

The Pitch is a new initiative from the team at The Sophisticated Investor. 

A typical management interview gives investors an update on recent results and short term targets, which is great for investors that are already informed about the company’s business.  However, new investors are typically left with more questions than answers as this is their first introduction to the company.

The Pitch aims to rectify this as we ask management to give us all the key information about the company in less than 3 minutes (or the time it takes to go up an elevator).  And as with all companies we interview, we only highlight those that we believe have strong long term fundamentals for investors.